NCT00998257View on ClinicalTrials.gov

Regulatory Post Marketing Surveillance Study on YAZ

CompletedOBSERVATIONAL

Enrollment

770

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

ContraceptionPremenstrual SyndromeAcne

Interventions

DRUG

EE20/DRSP (YAZ, BAY86-5300)

Patients under daily life treatment with YAZ according to local drug information.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY